dp-b99
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2005 (NCT00190047)
Timeline
Indications
Mechanism of action
- CalciumCHELATING AGENT
Calcium chelating agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dp-b99
- dp-b99
- dp-b99
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02025049 | Phase 2 | Dec 1, 2013 | D-Pharm Ltd. |
| NCT00893867 | Phase 3 | Dec 1, 2009 | Atrium Medisch Centrum, Heerlen, D-Pharm Ltd., Hospital Santa Marcelina, Sao Paulo, Brasil, University of Alberta |
| NCT00190047 | Phase 2 | Feb 1, 2005 | D-Pharm Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| D-Pharm Ltd. | For profit | 3 | 3 | 2 | 2005 |
| Atrium Medisch Centrum, Heerlen | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Hospital Santa Marcelina, Sao Paulo, Brasil | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Alberta | Academic/Hospital | 1 | 0 | 1 | 2009 |
4 organizations
Page 1 / 1